CIMO vs IONS
Chimera Investment Corporation (CIMO) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Chimera Investment Corporation (CIMO) common stock listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
CIMO does not have a complete income-statement cache yet.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
CIMO currently screens at market cap $0. IONS currently screens at market cap $12.28B.
Not investment advice. Open the CIMO and IONS stock pages for the full models.
Not investment advice.